TMIC-62. FYN, AN EFFECTOR OF ONCOGENIC RECEPTOR TYROSINE KINASES SIGNALING IN GLIOBLASTOMA, INHIBITS ANTI-GLIOMA IMMUNE RESPONSES: IMPLICATIONS FOR IMMUNOTHERAPY

There is currently much excitement for the use of immunotherapies in cancer. In spite of positive results using checkpoint inhibitors in melanoma and CAR T cells in leukemias, these strategies have not yet achieved robust clinical responses in human gliomas. A powerful inhibitory microenvironment is...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Comba, Andrea, J Dunn, Patrick, E Argento, Anna, Kadiyala, Padma, Ventosa, Maria, Patel, Priti, Zamler, Daniel, Nunez, Felipe, Zhao, Lili, Castro, Maria, Lowenstein, Pedro
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2019
Konular:
Tumor Microenvironment
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6845626/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.1096
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller